Ten post jest także dostępny w języku: polski
The SARS-CoV-2 coronavirus continues to spread around the world. However, there is one good message. Indeed, on Friday, the first company obtained official marketing authorisation for the COVID-19 vaccine in the United States. This is about Pfizer and BioNTech preparation.
FDA authorises the marketing of the first vaccine for COVID-19
“On 11 December 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older”.
The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S., was informed in an official communication.
COVID-19: Situation in Poland
Today, another 4,896 confirmed COVID-19 infections in Poland were reported. According to official data from the Ministry of Health in Poland, a total of 1,140,572 people were confirmed as having coronavirus SARS-CoV-2, 22,960 of whom lost the fight against this disease.
However, the government is preparing for mass vaccination, which is to start as soon as the COVID-19 vaccine is available in our country, we have written more about it here.